Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;42(8):e70010.
doi: 10.1002/cbf.70010.

Oxidative Stress Associated With Increased Reactive Nitrogen Species Generation in the Liver and Kidney Caused by a Major Metabolite Accumulating in Tyrosinemia Type 1

Affiliations

Oxidative Stress Associated With Increased Reactive Nitrogen Species Generation in the Liver and Kidney Caused by a Major Metabolite Accumulating in Tyrosinemia Type 1

Julia Gabrieli Bender et al. Cell Biochem Funct. 2024 Dec.

Abstract

Tyrosinemia type 1 (TT1) is caused by fumarylacetoacetate hydrolase activity deficiency, resulting in tissue accumulation of upstream metabolites, including succinylacetone (SA), the pathognomonic compound of this disease. Since the pathogenesis of liver and kidney damage observed in the TT1-affected patients is practically unknown, this study assessed the effects of SA on important biomarkers of redox homeostasis in the liver and kidney of adolescent rats, as well as in hepatic (HepG2) and renal (HEK-293) cultured cells. SA significantly increased nitrate and nitrite levels and decreased the concentrations of reduced glutathione (GSH) in the liver and kidney, indicating induction of reactive nitrogen species (RNS) generation and disruption of antioxidant defenses. Additionally, SA decreased the GSH levels and the activities of glutathione peroxidase, glutathione S-transferase, glutathione reductase, and superoxide dismutase in hepatic and renal cells. Noteworthy, melatonin prevented the SA-induced increase of nitrate and nitrite levels in the liver. Therefore, SA-induced increase of RNS generation and impairment of enzymatic and nonenzymatic antioxidant defenses may contribute to hepatopathy and renal disease in TT1.

Keywords: antioxidant defenses; reactive nitrogen species; redox homeostasis; succinylacetone; tyrosinemia type 1.

PubMed Disclaimer

References

    1. G. A. Mitchell, M. Grompe, M. Lambert, and R. M. Tanguay, “Hypertyrosinemia,” in The Online Metabolic and Molecular Bases of Inherited Disease, eds. D. L. Valle, S. Antonarakis, A. Ballabio, and G. A. Mitchell (McGraw Hill, 2019).
    1. F. J. van Spronsen, Y. Thomasse, P. G. A. Smit, et al., “Hereditary Tyrosinemia Type I: A New Clinical Classification With Difference in Prognosis on Dietary Treatment,” Hepatology 20, no. 5 (1994): 1187–1191.
    1. J. M. Chinsky, R. Singh, C. Ficicioglu, et al., “Diagnosis and Treatment of Tyrosinemia Type I: A US and Canadian Consensus Group Review and Recommendations,” Genetics in Medicine 19, no. 12 (2017): 1380–1395.
    1. C. de Laet, C. Dionisi‐Vici, J. V. Leonard, et al., “Recommendations for the Management of Tyrosinaemia Type 1,” Orphanet Journal of Rare Diseases 8 (2013): 8.
    1. S. Lindstedt, “Treatment of Hereditary Tyrosinaemia Type I by Inhibition of 4‐hydroxyphenylpyruvate Dioxygenase,” The Lancet 340, no. 8823 (1992): 813–817.

LinkOut - more resources